AMA launches Silicon Valley company to grow innovation footprint

The American Medical Association (AMA) has announced a $15 million investment to become founding partner of a healthcare innovation company, called Health2047, that will conduct rapid exploration of innovative solutions to the biggest challenges facing the nation’s 1.1 million physicians and the patients they serve.

“Improving the health of the nation is at the core of the AMA's work and Health2047 will build partnerships to create new solutions for physicians and their patients that improve healthcare delivery and health outcomes,” AMA CEO and executive vice president James L. Madara, MD, who serves as board chair of Health2047, said in a release. “Health2047’s product orientation and entrepreneurial DNA will help forge new paths and bring commercial solutions to market faster.”

Health2047 will be a standalone, for-profit entity and an integrated innovation company that combines strategy, design and venture disciplines, working in partnership with leading companies, physicians and entrepreneurs to improve healthcare, according to AMA. Its new Silicon Valley-based innovation studio will draw upon the AMA’s deep subject matter expertise and the organization’s unique relationship with physicians nationwide to develop new products, tools and resources that improve the practice of medicine and the delivery of healthcare to patients. Health2047 will collaborate with AMA content experts across a range of medical, health policy and practice areas as well as integrate healthcare companies, technology companies and entrepreneurs to co-develop, create and spin out offerings that can have large scale, systemic impact on healthcare and medical practice.

The AMA’s financial commitment to establish Health2047 represents a major step in expanding its innovation ecosystem. Recently the AMA has integrated innovation into its work resulting in internally generated physician-oriented digital tools as well as targeted engagement of healthcare startups.

“Our investment in Health2047 tangibly underscores the AMA’s ongoing commitment to innovation and collaboration in health care. This dynamic new environment will include the physician perspective in every major innovation cycle, ensuring that physicians play a greater role in leading changes that will move healthcare forward,” said Madara.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup